The risk of febrile neutropenia in patients with non-small-cell lung cancer treated with docetaxel: a systematic review and meta-analysis

Wailoo, A. orcid.org/0000-0002-9324-1617, Sutton, A. and Morgan, A. (2009) The risk of febrile neutropenia in patients with non-small-cell lung cancer treated with docetaxel: a systematic review and meta-analysis. British Journal of Cancer, 100 (3). pp. 436-441. ISSN 0007-0920

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2009 Cancer Research UK. Reproduced in accordance with the publisher's self-archiving policy.
Keywords: febrile neutropenia; docetaxel; meta-analysis; systematic review; randomized phase-III; 2nd-line therapy; clinical-trial; chemotherapy; regimens
Dates:
  • Published: 3 February 2009
  • Accepted: 4 December 2008
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Health and Related Research (Sheffield) > Sheffield Centre for Health and Related Research
Depositing User: Symplectic Sheffield
Date Deposited: 28 Nov 2016 16:25
Last Modified: 28 Nov 2016 16:27
Published Version: http://dx.doi.org/10.1038/sj.bjc.6604863
Status: Published
Publisher: Cancer Research UK
Refereed: Yes
Identification Number: https://doi.org/10.1038/sj.bjc.6604863

Download

Filename: The risk of febrile neutropenia in patients with non-small-cell lung cancer treated with docetaxel: a systematic review and meta-analysis.pdf

Share / Export

Statistics